Empagliflozin (JARDIANCE®) is proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease

Empagliflozin (JARDIANCE^®) is proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease

Empagliflozin (JARDIANCE) is simple and easy to use

Document ID: PC-PH-102970

21/03/2022

Author: Boehringer Ingelheim

123,000
Views

100k 340

Related content